DeutschNewstral
Article
bizjournals.com on 2015-11-23 13:41
Mallinckrodt, Horizon shares fall as concerns about Valeant business model spread
Related news
- Mallinckrodt receives subpoenasbizjournals.com
- Mallinckrodt expands share repurchasebizjournals.com
- Mallinckrodt downplays bankruptcy talkbizjournals.com
- Mallinckrodt sued by Tennessee prosecutorsbizjournals.com
- Mallinckrodt closes $185 million dealbizjournals.com
- Mallinckrodt completes $425 million dealbizjournals.com
- Mallinckrodt acquires regenerative medicine companybizjournals.com
- FValeant fears spread to drugmaker’s bondsft.com
- Mallinckrodt acquires pharmaceutical firm for $42 millionbizjournals.com
Mallinckrodt to Sell Nuclear-Imaging Operationswsj.com
Generic drugmaker Mallinckrodt settles 2 opioid lawsuitsartesianews.com
Drugmaker Mallinckrodt reaches $1.6B opioid settlementMerced Sun-Star- Mallinckrodt served subpoena for opioid informationbizjournals.com
- Mallinckrodt wraps up $203 million dealbizjournals.com
- Mallinckrodt finalizes $35 million settlement with DEAbizjournals.com
- Mallinckrodt faces lawsuit from Illinois citybizjournals.com